                         SEQUENCE LISTING

<110>  University of Florida Research Foundation, Incorporated
 
<120>  INHIBITION OF THE PDI FAMILY MEMBERS AGR2, PDIA1, AND ERP44 FOR 
       THERAPEUTIC TREATMENT AND USE IN PREDICTIVE 
       DIAGNOSTICS/MONITORING FOR TREATMENT REGIMENS

<130>  U1195.70190WO00

<140>  PCT/US2022/011961
<141>  2022-01-11

<150>  US 63/135,979
<151>  2021-01-11

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1
ttttggatcc caccatgcat cctgccgtct tcc                                    33


<210>  2
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2
ttttctcgag ttaaagctca tctcgatccc tc                                     32


<210>  3
<211>  47
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3
ctttagtaaa tttttatgct gactggagtc gtttcagtca gatgttg                     47


<210>  4
<211>  47
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4
caacatctga ctgaaacgac tccagtcagc ataaaaattt actaaag                     47


<210>  5
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5
gactggtgtc gtttctgtca gatgttgcat ccaatttttg                             40


<210>  6
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  6
caaaaattgg atgcaacatc tgacagaaac gacaccagtc                             40


<210>  7
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  7
ttttggatcc caccatggag aaaattccag tg                                     32


<210>  8
<211>  28
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  8
tttttacgta ttacaattca gtcttcag                                          28


<210>  9
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  9
ttttggatcc cagagatacc acagtcaaac                                        30


<210>  10
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  10
ttttgtcgac ttacaattca gtcttc                                            26


<210>  11
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  11
catcacttgg atgagtcccc acacagtcaa gc                                     32


<210>  12
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  12
gcttgactgt gtggggactc atccaagtga tg                                     32


<210>  13
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  13

Ser Xaa Xaa Ser 
1               


<210>  14
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  14

Cys Xaa Xaa Cys 
1               


<210>  15
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  15

Cys Pro His Ser 
1               


<210>  16
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  16

Cys Gln Tyr Ser 
1               


<210>  17
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  17

Cys Arg Phe Ser 
1               


<210>  18
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  18

Cys Xaa Xaa Ser 
1               


<210>  19
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  misc_feature
<222>  (3)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  19

Ser Cys Xaa Xaa Ser 
1               5   


